Founded by Dr. Elizabeth Ruzzo, adyn is helping people find birth control without side effects based on a person's genetic risk and hormone profile. Despite the 47M birth control users in the US, virtually no studies examine the biological factors that explain why individuals respond differently to a given contraceptive method.
Launched in May 2022, The Birth Control Test is the first test designed to prevent birth control side effects. While we are improving the birth control experience, we are also committed to closing the gender health gap. By partnering with individuals, adyn leverages personal preference, medical history, and biological data to proactively help every (unique) body select the most desirable birth control option – with the least dangerous side effects.
Our vision is to be earth’s most inclusive and patient-centric personalized medicine company. When a person uses The Birth Control Test, they can opt in as an anonymous research participant to help close these research gaps. This means you can simultaneously find the right birth control for your body, while helping others do the same.
Location: United States, Washington, Seattle
Employees: 1-10
Total raised: $2.5M
Founded date: 2020
Investors 2
Date | Name | Website |
- | Y Combinat... | ycombinato... |
02.11.2020 | Pioneer Fu... | pioneerfun... |
Funding Rounds 1
Date | Series | Amount | Investors |
19.04.2021 | Seed | $2.5M | Lux Capita... |
Mentions in press and media 4
Date | Title | Description | Source |
19.04.2021 | Seattle startup adyn raises $2.5M from 23andMe CEO and other... | adyn CEO Elizabeth Ruzzo. (adyn Photos) Seattle startup adyn raised a $2.5 million seed round co-le... | geekwire.c... |
19.04.2021 | adyn Raises $2.5M in Seed Funding | adyn, a Seattle, WA-based precision medicine company, closed a $2.5m seed round of funding. The rou... | finsmes.co... |
19.04.2021 | Precision medicine startup adyn raises $2.5 million in seed ... | Side effects are the #1 reason women switch birth control methods, with 52% of women trying four or ... | techstartu... |
19.04.2021 | Precision Medicine Company adyn Raises $2.5M Seed Funding fo... | adyn, a precision medicine company, announced today that it has closed a $2.5 million seed round of ... | marketscre... |